• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of October 17, 2012

  • Print
  • Share
  • E-mail
-

Event Detail

Event ID 62517
Product Type Biologics
Status Terminated
Recalling Firm Central California Blood Center
City Fresno
State CA
Country US
Voluntary/Mandated Voluntary: Firm Initiated
Recall Initiation Date 2012-06-12
Initial Firm Notification of
Consignee or Public
E-Mail
Distribution Pattern California; Florida

Product Detail

Product Description Code Info Classification Reason for Recall Product Quantity Recall Number
Red Blood Cells Leukocytes Reduced W115912230409; W115911273251; Class II Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed. 2 B-2303-12
Blood and Blood Products for Reprocessing W115911273251; Class II Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed. 1 B-2302-12
Plasma Frozen within 24 hours (FP24) W115912230409; Class II Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed. 1 B-2301-12
-
-